StreetAlpha.app
Home › Stocks › NHP

National Healthcare Properties, Inc. (NHP)

Real Estate
$14.55
▼ −0.68%
LAST CLOSE · NOV 17

National Healthcare Properties owns and manages U.S. senior housing communities and outpatient medical buildings leased to healthcare providers. It last closed at $14.55 on Nov 17, down 0.68% on the day. NHP reports earnings on Fri, Dec 4, 2026. The average 12-month price target from 3 analysts is $18.67 (+28.3% from the last close), with a high of $20.00 and a low of $18.00. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell).

AI Auto Pilots
Is NHP in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$361.4M
+4.6% vs a year ago
Net income
−$12.2M
−3.4% margin
Gross margin
36.5%
$131.7M gross profit
Operating margin
11.2%
$40.4M operating income
Valuation
Market cap
$1.1B
73.0M shares
P/E
–
Price to sales
2.9
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$125.1M
At Sep 30
Shareholder equity
$918.2M
Shares outstanding
73.0M
At Oct 30
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $329.4M$329.4MFY2021FY2022: $335.8M$335.8MFY2022FY2023: $345.9M$345.9MFY2023FY2024: $353.8M$353.8MFY2024FY2025: $342.3M$342.3MFY2025

From NHP's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 6). Last 12 months adds up the four latest quarters.

Next report
Dec 4
2026 · Time not announced
Consensus EPS forecast
$0.87
$95.0M revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
Strong Buy
Based on 3 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
3firms
3 Buy0 Hold0 Sell
Each firm's latest rating on NHP in the past 90 days
Average 12-month target
$18.67
▲ 28.3% upside

Based on 3 analysts who set a price target on NHP in the past 90 days. The average target is $18.67, with a high of $20.00 and a low of $18.00, compared with the last close of $14.55.

Low $18.00Avg $18.67High $20.00
Blue marker: last close $14.55
Highest target$20.00
Average target$18.67
Lowest target$18.00
Latest rating changes
Wells FargoMaintained
Oct 19Buy$18
Raymond JamesInitiated
Oct 13Buy$20
Wells FargoTarget raised
Sep 1Buy$17 → $19
BairdTarget raised
Aug 20Buy$17 → $18
RBC CapitalTarget raised
Aug 17Hold$15 → $17
DateFirmActionRatingPrice target
Oct 19Wells FargoMaintainedBuy$18
Oct 13Raymond JamesInitiatedBuy$20
Sep 1Wells FargoTarget raisedBuy$17 → $19
Aug 20BairdTarget raisedBuy$17 → $18
Aug 17RBC CapitalTarget raisedHold$15 → $17
Loading…

Technical Analysis

NHP · as of the Nov 17 close · updated after every close
Falling

The stock is 5% below its 20 day and 7% below its 50 day average. Momentum is weak (RSI 40). The nearest support is the swing low (Jul 17) at $14.47, and the nearest resistance the Pivot at $14.58.

Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNormal
VolatilityNormal, 4.7%/day
Key levels
$17.4652 week high+20.0%
$15.73100 day average+8.1%
$15.5650 day average+6.9%
$15.30Swing high (Jun 8)+5.2%
$15.2320 day average+4.7%
$14.81Pivot R1+1.8%
$14.58Pivot+0.2%
$14.55Last close
$14.47Swing low (Jul 17)−0.5%
$14.33Pivot S1−1.5%
$11.2552 week low−22.7%
Indicators
RSI (14)39.67Weak, oversold below 30Neutral
MACD-0.14Below its signal lineBearish
Stochastic23.5Middle of its rangeNeutral
ADX (14)13.8No clear trend
Williams %R-86.8Oversold below −80, overbought above −20Oversold
CCI (20)-126.2Oversold below −100, overbought above 100Oversold
Rate of change−6.1%Change over 10 sessionsBearish
ATR (14)$0.68Typical daily range, 4.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for NHP

What happened before

See how NHP did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Whale Options Flow

90D

No whale options trades in NHP in the last 90 days.

Loading…

See today’s whale options flow across the market →

NHP Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲12 buying vs 2 selling
  • ▲Held by funds +1.5 pts
  • ▲Funds holding +10
  • ●No superinvestor moves
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding133+333.3%
In funds' top 1000–
Held by funds1.5%0.0%+1.5 pts
New / increased12 / 01 / 0+1100.0%
Reduced / sold out0 / 20 / 3−33.3%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See NHP institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether NHP is in one of them and how their past NHP trades turned out.

NHP in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered NHP in an article yet. Here's the latest on the wider market.

About National Healthcare Properties

National Healthcare Properties is a real estate investment trust that owns and manages healthcare properties in the United States. Its senior housing communities offer assisted living and memory care, with residents generally paying for services directly or through private insurance. Its outpatient medical facilities are leased to tenants such as physicians, diagnostic imaging centers, rehabilitation clinics and ambulatory surgery centers, with some located near hospital campuses. The company is based in New York.

Headquarters
New York, NY